Bio Feature
mRNA Vaccine Technology Holds Promise, but Faces Challenges
Numerous studies and statistics from national governments also suggest the data looks good regarding how the mRNA vaccines perform against emerging variant...
June 24, 2021 | Opinion
Antengene continued to execute its dual-engine growth strategy
Announces two new in-house discovered assets - ATG-031, a potential first-in-class anti-CD24 monoclonal antibody, and ATG-027, a potential first-in-class...
June 18, 2021 | News
To win the race against Covid-19, enabling access to vaccinations is key
When the first Covid-19 vaccine was approved for use in late 2020, it marked a momentous achievement in science. It was the result of an urgent and ...
June 11, 2021 | News | By Leonora Lim, Vice President at DHL Customer Solutions and Innovation, Life Sciences and Healthcare.
Finding the cure for vaccine hesitancy
As COVID-19 swept across the world last year, the race to develop a vaccine went into overdrive. The speed was unprecedented. Something that typicall...
June 10, 2021 | News
Karyopharm Announces Key Changes to Its Commercial Leadership Team
Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced key managemen...
June 09, 2021 | News
Thyroid health – why is it important for mothers? : Prof. Dr. med. Frank-Raue
Thyroid disorders affect an estimated 350 million people worldwide1,2 and are especially common in women.3 Sadly, when undiagnosed, t...
May 31, 2021 | Opinion
The Cost of Under- and Over-Coating Zinc
But for manufacturers who provide these zinc-coated products, the cost of zinc has increased substantially over the past few years, emphasizing the need to...
May 26, 2021 | Opinion | By By Chris Burnett
Discovery Makers: Dorraya El-Ashry
Discovery Makers: Dorraya El-Ashry What keeps a scientist going through doubts and difficulties? Rock-solid self-belief? The drive to save lives? Curiou...
May 25, 2021 | Opinion
Evolution of Ivermectin as a Drug of Choice for Prevention & Treatment of Covid-19: Dr. Surya Kant
There are newer drugs on the horizon which have been recommended though with very limited experience & devoid of enough data about safety and eff...
May 10, 2021 | Opinion
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
